Validating Consensus on Post TAVR Conduction Disturbances in the Clinical Practice

Little over a year ago, JACC published the expert consensus on the management of post transcatheter aortic valve replacement (TAVR) conduction disturbances. This publication homogenized criteria and was welcomed by operators who, when in doubt, tended to prematurely indicate definite pacemaker implantation or delayed discharge in order to monitor patients. 

El consenso sobre trastornos de conducción post TAVI a prueba en la práctica clínica

These criteria, however, was nothing but expert consensus to be validated over time, especially in the daily clinical practice

This analysis was based on a registry that classified patients using the consensus algorithm: patients eligible for early discharge (1 or 2 days after TAVR); patients at high risk of high degree atrioventricular block who require additional monitoring; and patients with pacemaker indication. 

Primary end point was pacemaker implantation rate for high degree or complete block at 30 days. All patients with prior pacemaker, valve in valve or electrocardiogram were excluded. 

Of 1439 patients undergoing TAVR between 2014 and 2019, 73% were eligible for early discharge, 21% were at high risk of complete block and the remaining 6% required pacemaker implantation. 


Read also: Experts Reach Consensus on Post TAVR Pacemaker Indication.


Pacemaker implantation rate 30 days after TAVR was 16% (234 patients). 2.7% of the group eligible for early discharge finally required a pacemaker within 30 days after TAVR, and so did 41% of the high-risk group and 100% of those with pacemaker indication. 

Conclusion

The expert consensus on post TAVR conduction disturbances was able to safely identify patients needing a pacemaker. This strategy allows a more uniform management, facilitates early discharge of low-risk patients, and prevents prolonging unnecessary monitoring 3 out of 4 patients

Original Title: Validation of the 2019 Expert Consensus Algorithm for the Management of Conduction Disturbances After TAVR.

Reference: Daniel Malebranche et al. J Am Coll Cardiol Intv. 2021 May, 14 (9) 981–991.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques, M-TEER using the MitraClip...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques, M-TEER using the MitraClip...